{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:01Z","timestamp":1761058621353},"reference-count":42,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"DOI":"10.1210\/jc.2006-2684","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T02:57:43Z","timestamp":1171421863000},"page":"1710-1714","source":"Crossref","is-referenced-by-count":41,"title":["Combined Low-Dose Pioglitazone, Flutamide, and Metformin for Women with Androgen Excess"],"prefix":"10.1210","volume":"92","author":[{"given":"Lourdes","family":"Iba\u0301n\u0303ez","sequence":"first","affiliation":[{"name":"Endocrinology Unit (L.I.), Hospital Sant Joan de De\u0301u, University of Barcelona, 08950 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Lo\u0301pez-Bermejo","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology, and Nutrition Unit (A.L.-B.), Dr. Josep Trueta Hospital, 17007 Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"del Rio","sequence":"additional","affiliation":[{"name":"Cetir Centre Me\u0300dic (L.d.R.), 08029 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goya","family":"Enri\u0301quez","sequence":"additional","affiliation":[{"name":"Department of Radiology (G.E.), Hospital Materno-Infantil Vall d\u2019Hebron, Autonomous University of Barcelona, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Valls","sequence":"additional","affiliation":[{"name":"Hormonal Laboratory (C.V.), Hospital Sant Joan de De\u0301u, University of Barcelona, 08950 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"de Zegher","sequence":"additional","affiliation":[{"name":"Department of Woman and Child (F.d.Z.), University of Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113582765500_R1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome.","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113582765500_R3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/humupd\/dmi054","article-title":"Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.","volume":"12","author":"Iba\u0301n\u0303ez","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041113582765500_R5","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2337\/diacare.28.2.488","article-title":"Thiazolidinediones.","volume":"28","author":"Bloomgarden","year":"2005","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113582765500_R7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113582765500_R8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2005.12.067","article-title":"Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.","volume":"86","author":"Glintborg","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113582765500_R9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2165\/00003495-200262100-00004","article-title":"Metabolic and additional vascular effects of thiazolidinediones.","volume":"62","author":"Martens","year":"2002","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019041113582765500_R10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diabres.2005.02.011","article-title":"Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.","volume":"70","author":"Belcher","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"key\n\t\t\t\t2019041113582765500_R11","first-page":"227","article-title":"Insulin resistance: classification, prevalence, clinical manifestations, and diagnosis","author":"Vidal-Puig","year":"1997","journal-title":"In: Azziz R, Nestler JE, Dewailly D, eds. Androgen excess disorders in women. Philadelphia: Lippincott-Raven Publishers;"},{"key":"key\n\t\t\t\t2019041113582765500_R12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and young women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.","volume":"89","author":"Iba\u0301n\u0303ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/humrep\/deh329","article-title":"Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.","volume":"19","author":"Iba\u0301n\u0303ez","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113582765500_R15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113582765500_R16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.","volume":"56","author":"New","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jc.2004-1552","article-title":"Refining hormonal diagnosis of type II 3\u03b2-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.","volume":"90","author":"Mermejo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R18","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1210\/jc.2004-0047","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and anti-atherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.","volume":"89","author":"Iba\u0301n\u0303ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/humrep\/del395","article-title":"Polycystic ovaries after precocious pubarche: relation to prenatal growth.","volume":"22","author":"Iba\u0301n\u0303ez","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113582765500_R20","doi-asserted-by":"crossref","first-page":"18L","DOI":"10.1016\/S0002-9149(02)02957-0","article-title":"Intima-media thickness: a tool for atherosclerosis imaging and event prediction","volume":"90","author":"O\u2019Leary","year":"2002","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041113582765500_R21","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/01.STR.0000035736.30488.7A","article-title":"Bilateral symmetry of human carotid atherosclerosis.","volume":"23","author":"Adams","year":"2002","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041113582765500_R22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/JCD:3:1:035","article-title":"Measurement precision of body composition variables using the Lunar DPX-L densitometer.","volume":"3","author":"Kiebzak","year":"2000","journal-title":"J Clin Densitometry"},{"key":"key\n\t\t\t\t2019041113582765500_R23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.ijo.0801982","article-title":"Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass?","volume":"26","author":"Park","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key\n\t\t\t\t2019041113582765500_R24","doi-asserted-by":"crossref","first-page":"E124","DOI":"10.1152\/ajpendo.2000.279.1.E124","article-title":"Weight loss in postmenopausal obesity: no adverse alterations in body composition and protein metabolism","volume":"279","author":"Gallagher","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R25","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/humrep\/dei072","article-title":"High neutrophil count in girls and women with hyperinsulinemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.","volume":"20","author":"Iba\u0301n\u0303ez","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113582765500_R26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/humrep\/dei329","article-title":"Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinemic hyperandrogenism: normalizing effects on C-reactive protein, tumor necrosis factor-\u03b1 and the neutrophil\/lymphocyte ratio.","volume":"21","author":"Iba\u0301n\u0303ez","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113582765500_R27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00041552-200501000-00006","article-title":"Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role.","volume":"14","author":"Venugopal","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t2019041113582765500_R28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/dmrr.647","article-title":"Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus.","volume":"23","author":"Tsai","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"key\n\t\t\t\t2019041113582765500_R29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","article-title":"Which white blood cell subtypes predict increased cardiovascular risk?","volume":"45","author":"Horne","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041113582765500_R30","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2337\/diacare.26.9.2493","article-title":"Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect.","volume":"26","author":"Satoh","year":"2003","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113582765500_R31","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.296.21.joc60158","article-title":"Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes. A randomized trial.","volume":"296","author":"Mazzone","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113582765500_R32","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome.","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R33","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R34","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1210\/jc.2005-0615","article-title":"Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.","volume":"90","author":"Glintborg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/endo.134.2.8299559","article-title":"Pioglitazone inhibits the diabetogenic action of growth hormone but not its ability to promote growth.","volume":"134","author":"Towns","year":"1994","journal-title":"Endocrinology"},{"issue":"Suppl 8A","key":"key\n\t\t\t\t2019041113582765500_R36","doi-asserted-by":"crossref","first-page":"111S","DOI":"10.1016\/j.amjmed.2003.09.018","article-title":"Considerations for management of fluid dynamic issues associated with thiazolidinediones","volume":"115","author":"Hollenberg","year":"2003","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113582765500_R37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clpt.2006.03.014","article-title":"Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.","volume":"80","author":"Berria","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041113582765500_R38","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome.","volume":"91","author":"Setji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R39","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/humrep\/dei004","article-title":"Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.","volume":"20","author":"Iba\u0301n\u0303ez","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113582765500_R40","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1210\/jc.2003-030117","article-title":"Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.","volume":"88","author":"Iba\u0301n\u0303ez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2004-1405","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and anti-atherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at start and after more than one year of therapy.","volume":"90","author":"Iba\u0301n\u0303ez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582765500_R42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1507\/endocrj.K05-067","article-title":"Safety and efficacy of low-dose pioglitazone (7.5 mg\/day) vs. standard-dose pioglitazone (15 mg\/day) in Japanese women with type 2 diabetes mellitus.","volume":"53","author":"Majima","year":"2006","journal-title":"Endocr J"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/5\/1710\/9052607\/jcem1710.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T16:20:21Z","timestamp":1556122821000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/5\/1710\/2598363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-2684","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}